These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 498718)

  • 41. The effect of glucose on acetylation status.
    Suhardjono D; Boutagy J; Shenfield GM
    Br J Clin Pharmacol; 1986 Oct; 22(4):401-8. PubMed ID: 3768255
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes.
    Hadasová E; Brysová V; Utĕsený J; Macků M
    Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Potential influence of body weight on the clearance of polymorphically acetylated drugs.
    Chapron DJ; Kramer PA; Mercik SA
    J Clin Pharmacol; 1982; 22(5-6):271-5. PubMed ID: 7107974
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphic N-acetylation of a caffeine metabolite.
    Grant DM; Tang BK; Kalow W
    Clin Pharmacol Ther; 1983 Mar; 33(3):355-9. PubMed ID: 6825389
    [TBL] [Abstract][Full Text] [Related]  

  • 45. N-acetylation in healthy and diseased children.
    Hadasová E; Brysová V; Kadlcáková E
    Eur J Clin Pharmacol; 1990; 39(1):43-7. PubMed ID: 2276387
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kinetics of acetyl CoA: arylamine N-acetyltransferase from rapid and slow acetylator human liver.
    Kilbane AJ; Petroff T; Weber WW
    Drug Metab Dispos; 1991; 19(2):503-7. PubMed ID: 1676662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Acetylation phenotype in colorectal carcinoma.
    Ilett KF; David BM; Detchon P; Castleden WM; Kwa R
    Cancer Res; 1987 Mar; 47(5):1466-9. PubMed ID: 3815349
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
    Clark DW
    Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the acetylation of procainamide and sulfadimidine in man.
    Frislid K; Berg M; Hansteen V; Lunde PK
    Eur J Clin Pharmacol; 1976 Mar; 09(5-6):433-8. PubMed ID: 971707
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The acetylator phenotypes of Saudi Arabians with coronary arterial atheroma.
    Evans DA; Wicks J; Higgins J; Assisto M
    J Med Genet; 1991 Mar; 28(3):192-3. PubMed ID: 2051455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Polymorphic acetylation of sulfamethazine in a Nigerian (Yoruba) population.
    Jeyakumar LH; French MR
    Xenobiotica; 1981 May; 11(5):319-21. PubMed ID: 7293222
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphic acetylation of sulphamethazine in man: acetylator phenotype in sicklers and non-sicklers.
    Jeyakumar LH; French MR
    Toxicol Lett; 1980 Sep; 6(4-5):263-5. PubMed ID: 7423555
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The potential clinical significance of the isoniazid acetylator phenotype in the treatment of pulmonary tuberculosis].
    Ellard GA
    Rev Mal Respir; 1984; 1(4):207-19. PubMed ID: 6505358
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ethanol-induced increase in drug acetylation in man and isolated rat liver cells.
    Olsen H; Mørland J
    Br Med J; 1978 Nov; 2(6147):1260-2. PubMed ID: 709306
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 4-Aminobiphenyl downregulation of NAT2 acetylator genotype-dependent N- and O-acetylation of aromatic and heterocyclic amine carcinogens in primary mammary epithelial cell cultures from rapid and slow acetylator rats.
    Jefferson FA; Xiao GH; Hein DW
    Toxicol Sci; 2009 Jan; 107(1):293-7. PubMed ID: 18842621
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Acetylator phenotype in psoriasis.
    Jiménez-Nieto LC; Ladero JM; Fernández-Gundín MJ; Robledo A
    Dermatologica; 1989; 178(3):136-7. PubMed ID: 2721804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Competitive binding of sulfamethazine and its N-acetylated metabolite.
    Tsang YC; Thiessen JJ
    Biopharm Drug Dispos; 1989; 10(5):465-79. PubMed ID: 2804251
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulfadimidine and isoniazid loading in man and laboratory rats. Pharmacokinetic and pharmacogenetic results on drug acetylation.
    Dubbels R; Kattner E; Sell-Maurer D; Schloot W
    Arzneimittelforschung; 1980; 30(9):1574-9. PubMed ID: 7193028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and renal clearance of sulfamethazine, sulfamerazine, and sulfadiazine and their N4-acetyl and hydroxy metabolites in horses.
    Nouws JF; Firth EC; Vree TB; Baakman M
    Am J Vet Res; 1987 Mar; 48(3):392-402. PubMed ID: 3565894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.